Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients

NCT00499889 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

42

Enrollment

OTHER

Sponsor class

Stopped Support issue.

Conditions

Leukemia

Interventions

DRUG: Imatinib Mesylate
DRUG: Fludarabine (Fludara)
DRUG: Busulfan
DRUG: Antithymocyte Globulin (ATG)
DRUG: Tacrolimus
DRUG: Methotrexate
PROCEDURE: Donor lymphocyte infusion (DLI)
PROCEDURE: Stem Cell Transplant

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]